Atherosclerosis
Volume 199, Issue 1 , Pages 138-146 , July 2008

NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells’ response to cardiac surgery

  • Francesca Cesari

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy
    • Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • Corresponding Author InformationCorresponding author at: Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy. Tel.: +39 055 7949420; fax: +39 055 7949418.
    • ,
  • Roberto Caporale

      Affiliations

    • Central Laboratory, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Rossella Marcucci

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy
    • Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Sabina Caciolli

      Affiliations

    • Unit of Cardiac Surgery, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Pier Luigi Stefano

      Affiliations

    • Unit of Cardiac Surgery, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Andrea Capalbo

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy
    • Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Claudio Macchi

      Affiliations

    • Centro S. Maria agli Ulivi, Fondazione Don Carlo Gnocchi Onlus IRCCS, Impruneta, Florence, Italy
    • ,
  • Mauro Vannucci

      Affiliations

    • Unit Of Cardiologic Rehabilitation I.F.C.A. “Ulivella e Glicini”, Florence, Italy
    • ,
  • Gian Franco Gensini

      Affiliations

    • Centro S. Maria agli Ulivi, Fondazione Don Carlo Gnocchi Onlus IRCCS, Impruneta, Florence, Italy
    • ,
  • Rosanna Abbate

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy
    • Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Anna Maria Gori

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134 Florence, Italy
    • Center for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Received 12 June 2007 ,Revised 19 September 2007 ,Accepted 27 September 2007.

References 

  1. Insner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231–1236
  2. Vasa M, Fichtlschererer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885–2890
  3. Werner N, Priller J, Laufs U, et al. Bone-marrow derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002;22:1567–1572
  4. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102:1340–1346
  5. Pistrosch F, Herbrig K, Oelschlaegel U, et al. PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis. 2005;185:163–167
  6. Bahlmann F, De Groot K, Mueller O, et al. Stimulation of Endothelial progenitor cells: a new putative therapeutic effect of Angiotensin II receptor antagonists. Hypertension. 2005;45:526–529
  7. Moore MA, Hattori K, Heissig B, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci. 2001;938:36–45
  8. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97:3354–3360
  9. Shomig K, Busch G, Steppich B, et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J. 2006;27:1032–1037
  10. Verma S, Kuliszewski MA, Li SH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004;109:2058–2067
  11. Herbrig K, Haensel S, Oelschlaegel U, et al. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis. 2006;65:157–163
  12. Wojakowski W, Tendera M, Zebzda A, et al. Mobilization of CD34+, CD117+, CXCR4+, c-met+ stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J. 2006;27:283–289
  13. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007
  14. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+ AC133+ endothelial precursor cells. Circ Res. 2001;88:167–174
  15. Scheubel RJ, Zorn H, Silber R, et al. Age dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2003;42:2073–2080
  16. Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg. 2007;83:598–605
  17. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. ESH/ESC hypertension guidelines committee. Hypertension. 2003;21:1779–1786
  18. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care. 2003;26:5–20
  19. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421
  20. Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314–322
  21. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391–397
  22. Tanaka T, Kanda T, Takahashi T, et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res. 2004;32:57–61
  23. Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34:2140–2144

PII: S0021-9150(07)00609-0

doi: 10.1016/j.atherosclerosis.2007.09.045

Atherosclerosis
Volume 199, Issue 1 , Pages 138-146 , July 2008

Article Tools

* Image Usage & Resolution